Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.63
+0.58009.59%
Post-market: 6.640.0100+0.15%16:39 EDT
Volume:914.65K
Turnover:5.92M
Market Cap:359.86M
PE:-2.70
High:6.67
Open:6.17
Low:6.16
Close:6.05
Loading ...

Emergent BioSolutions teams up with Victoria’s Voice Foundation

TIPRANKS
·
05 Jun

Emergent BioSolutions Faces Derivative Litigation Over Alleged Breaches of Fiduciary Duty and Regulatory Failures

Reuters
·
31 May

Director Keith Katkin Reports Disposal of Common Shares of Emergent BioSolutions Inc

Reuters
·
29 May

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split Effective May 23, 2025

Reuters
·
24 May

Emergent BioSolutions Faces Multiple Lawsuits Over Securities Fraud and Manufacturing Failures

Reuters
·
24 May

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance

Reuters
·
22 May

BUZZ-U.S. STOCKS ON THE MOVE-CFSB Bancorp, B Riley, Dycom Industries

Reuters
·
21 May

Aptevo Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

Emergent BioSolutions rises 14.6%

TIPRANKS
·
17 May

Emergent BioSolutions Inc. to Participate in RBC Global Healthcare Conference in New York

Reuters
·
14 May

Emergent BioSolutions’ Earnings Call: A Balanced Outlook

TIPRANKS
·
09 May

Emergent BioSolutions rises 29.3%

TIPRANKS
·
09 May

Emergent BioSolutions Reports Strong Q1 2025 Earnings

TIPRANKS
·
08 May

Emergent BioSolutions Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Emergent BioSolutions Q1 Adj. EPS $0.71 Beats $0.44 Estimate, Sales $222.20M Beat $219.00M Estimate

Benzinga
·
08 May

BRIEF-Emergent BioSolutions Q1 Revenue USD 222.2 Million

Reuters
·
08 May

Emergent BioSolutions Stockholders Elect Directors at Meeting

TIPRANKS
·
07 May

Aptevo Therapeutics Inc expected to post a loss of $4.21 a share - Earnings Preview

Reuters
·
06 May

Emergent BioSolutions Inc expected to post earnings of 44 cents a share - Earnings Preview

Reuters
·
06 May

Aptevo Therapeutics Inc expected to post a loss of $4.21 a share - Earnings Preview

Reuters
·
02 May